The Science Behind Dual Agonists The next generation of weight loss medications combines GLP-1 action with another hormone called GIP (glucose-dependent insulinotropic polypeptide)
Patients who couldn't afford the $900$1,300 monthly brand-name cost found relief through compounded versions priced anywhere from $150 to $400 per month
The patients clinical evaluation revealed that his clinical profile was complicated by several comorbidities, including bipolar disorder, generalized anxiety disorder, and obstructive sleep apnea (OSA)
Nadia El-M
If a GLP-1 agonist is, in fact, the best option for a patient, they can comparison shop
From other GLP-1 receptor agonists to next-generation triple agonists, compounded peptides to non-peptide prescription medications, the alternatives range from nearly equivalent to genuinely different approaches